Durham firm developing drugs for hypertension raises $3.2M in debt

Posted by | Jul 15, 2019

Adhera Therapeutics raised the funds from 45 investors — with a minimum $10,000 investment accepted from any outside investor, according to the recent SEC filing.

Read More